Notice: This company has been marked as potentially delisted and may not be actively trading. Graphite Bio (GRPH) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CarbonScape plans to build biographite plant in FinlandSeptember 18, 2024 | finance.yahoo.comVersant Vantage II, L.P.'s Net WorthMay 16, 2024 | benzinga.comTrading was temporarily halted for "GRPH" at 07:03 PM with a stated reason of "News pending."March 22, 2024 | marketbeat.comLENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate ProgressMarch 21, 2024 | finance.yahoo.comGraphite Bio Stock Set to Reverse Split on Friday, March 22nd (NASDAQ:GRPH)Graphite Bio, Inc. (NASDAQ:GRPH - Free Report)'s stock is going to reverse split before the market opens on Friday, March 22nd. The 1-7 reverse split was announced on Friday, March 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, March 22nd.March 20, 2024 | marketbeat.comGRPH Mar 2024 5.000 putMarch 15, 2024 | finance.yahoo.comVERI, STI and VERB among mid-day moversMarch 15, 2024 | seekingalpha.comGRPH Mar 2024 7.500 callMarch 15, 2024 | finance.yahoo.comGraphite Bio, Inc. Declares Dividend of $1.03 (NASDAQ:GRPH)Graphite Bio, Inc. (NASDAQ:GRPH) announced a dividend on Friday, March 15th. Shareholders of record on Monday, March 18th will be given a dividend of 1.03 per share on Thursday, March 21st. This represents a yield of 28.93%. The ex-dividend date is Friday, March 15th.March 15, 2024 | marketbeat.comTrading was temporarily halted for "GRPH" at 07:03 PM with a stated reason of "News pending."March 15, 2024 | marketbeat.comGraphite Bio, Inc. (GRPH)March 14, 2024 | finance.yahoo.comGraphite Bio to Pay Special Dividend Linked to Lenz Therapeutics MergerMarch 10, 2024 | marketwatch.comGraphite Bio announces $1.03 per share special dividendMarch 8, 2024 | au.investing.comGraphite Bio declares special $1.03 dividendMarch 8, 2024 | msn.comGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsMarch 8, 2024 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHFebruary 27, 2024 | businesswire.comShort Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Decreases By 31.5%Graphite Bio, Inc. (NASDAQ:GRPH - Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 801,800 shares, a decline of 31.5% from the January 15th total of 1,170,000 shares. Based on an average trading volume of 177,600 shares, the short-interest ratio is presently 4.5 days. Approximately 2.9% of the shares of the stock are short sold.February 13, 2024 | marketbeat.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graphite Bio, Inc. (GRPH)February 2, 2024 | markets.businessinsider.comShort Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Decreases By 6.0%Graphite Bio, Inc. (NASDAQ:GRPH - Get Free Report) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 1,260,000 shares, a decline of 6.0% from the November 30th total of 1,340,000 shares. Based on an average daily trading volume, of 162,900 shares, the short-interest ratio is presently 7.7 days. Currently, 4.6% of the shares of the company are sold short.January 3, 2024 | marketbeat.comGraphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 TrialDecember 25, 2023 | seekingalpha.comShort Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Rises By 8.9%Graphite Bio, Inc. (NASDAQ:GRPH - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 1,340,000 shares, an increase of 8.9% from the November 15th total of 1,230,000 shares. Currently, 4.9% of the company's stock are short sold. Based on an average daily volume of 136,600 shares, the days-to-cover ratio is presently 9.8 days.December 16, 2023 | marketbeat.comGraphite Bio (GRPH) Price Target Increased by 40.00% to 7.14November 27, 2023 | msn.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 17, 2023 | businesswire.comShareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ TherapeuticsNovember 16, 2023 | benzinga.comShattered dream of sickle cell disease cure to end in reverse merger for Peninsula biotechNovember 16, 2023 | bizjournals.comWhat Makes Graphite Bio, Inc. (GRPH) a New Buy StockNovember 16, 2023 | finance.yahoo.comGRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to ShareholdersNovember 15, 2023 | benzinga.comGraphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-marketNovember 15, 2023 | markets.businessinsider.comLENZ Therapeutics and Graphite Bio Announce Merger AgreementNovember 15, 2023 | finance.yahoo.comTrading was temporarily halted for "GRPH" at 06:11 AM with a stated reason of "News pending."November 15, 2023 | marketbeat.comGraphite Bio Inc GRPHNovember 9, 2023 | morningstar.comGraphite Bio (GRPH) Price Target Increased by 25.00% to 5.10November 1, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 11.11% to 4.08October 5, 2023 | msn.comBoard of Trustees of The Leland Stanford Junior University Purchases 243,784 Shares of Graphite Bio, Inc. (NASDAQ:GRPH)Board of Trustees of The Leland Stanford Junior University raised its stake in shares of Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) by 53.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 703,071 sSeptember 12, 2023 | marketbeat.comAldebaran Capital LLC Invests $318,000 in Graphite Bio, Inc. (NASDAQ:GRPH)Aldebaran Capital LLC bought a new position in Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 130,000 shares of the company's stock, valued at approximately $318,000.August 25, 2023 | marketbeat.comBrokers Set Expectations for Graphite Bio, Inc.'s FY2023 Earnings (NASDAQ:GRPH)Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) - Equities research analysts at Cantor Fitzgerald dropped their FY2023 earnings per share estimates for shares of Graphite Bio in a research note issued on Thursday, August 17th. Cantor Fitzgerald analyst O. Brayer now anticipates that the company wiAugust 21, 2023 | marketbeat.comFederated Hermes Inc. Has $1 Million Holdings in Graphite Bio, Inc. (NASDAQ:GRPH)Federated Hermes Inc. lessened its stake in Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) by 61.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 409,962 shares of the company's stock after selling 648,539 shares during theAugust 20, 2023 | marketbeat.comFY2023 EPS Estimates for Graphite Bio, Inc. (NASDAQ:GRPH) Decreased by AnalystGraphite Bio, Inc. (NASDAQ:GRPH - Free Report) - Equities research analysts at Leerink Partnrs cut their FY2023 earnings estimates for Graphite Bio in a research report issued to clients and investors on Tuesday, August 15th. Leerink Partnrs analyst M. Foroohar now anticipates that the company wiAugust 18, 2023 | marketbeat.comGraphite Bio CFO resigns to pursue other opportunitiesJune 23, 2023 | seekingalpha.comGraphite Bio Announces Departure of Chief Financial OfficerJune 23, 2023 | finance.yahoo.comGraphite Bio, Inc. (NASDAQ:GRPH) Receives Average Recommendation of "Reduce" from AnalystsGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) has been given an average rating of "Reduce" by the nine brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the comJune 20, 2023 | marketbeat.comEcoR1 Capital LLC Increases Stock Position in Graphite Bio, Inc. (NASDAQ:GRPH)EcoR1 Capital LLC raised its holdings in Graphite Bio, Inc. (NASDAQ:GRPH - Get Rating) by 261.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,712,096 shares of the company's stock after purchasJune 9, 2023 | marketbeat.comGraphite Bio, Inc. (NASDAQ:GRPH) Given Average Rating of "Reduce" by BrokeragesShares of Graphite Bio, Inc. (NASDAQ:GRPH - Get Rating) have received an average rating of "Hold" from the nine research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and eight have given a hold rating to the company. TMay 26, 2023 | marketbeat.comFY2023 EPS Estimates for Graphite Bio, Inc. (NASDAQ:GRPH) Cut by AnalystGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) - Research analysts at Cantor Fitzgerald decreased their FY2023 earnings per share (EPS) estimates for Graphite Bio in a research report issued on Tuesday, May 16th. Cantor Fitzgerald analyst O. Brayer now forecasts that the company will post earningsMay 19, 2023 | marketbeat.comSVB Securities Sticks to Their Hold Rating for Graphite Bio (GRPH)May 15, 2023 | markets.businessinsider.comGraphite Bio, Inc.'s (NASDAQ:GRPH) largest shareholders are private equity firms with 43% ownership, institutions own 22%May 15, 2023 | finance.yahoo.comShould You Buy Graphite Bio (GRPH) Ahead of Earnings?May 10, 2023 | finance.yahoo.comGraphite Bio, Inc. (NASDAQ:GRPH) Given Average Recommendation of "Hold" by AnalystsGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) has been assigned a consensus recommendation of "Hold" from the nine brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation and eight have given a hold recommendation toMay 1, 2023 | marketbeat.comGraphite Bio, Inc. (NASDAQ:GRPH) Given Consensus Rating of "Hold" by AnalystsGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) has earned a consensus rating of "Hold" from the nine analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the companyApril 6, 2023 | marketbeat.com Get Graphite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. GRPH Media Mentions By Week GRPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRPH News Sentiment▼0.000.46▲Average Medical News Sentiment GRPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRPH Articles This Week▼00▲GRPH Articles Average Week Get Graphite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVIR News Today AVRO News Today BLUE News Today MBIO News Today YMAB News Today AVXL News Today ADPT News Today TECX News Today EXAI News Today TRML News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graphite Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graphite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRPH Stock Alerts